The Lancet Infectious Diseases 2024

4 papers
In 2024, The Lancet Infectious Diseases featured research focused on vaccine efficacy, zoonotic transmission, and the long-term impacts of viral infections. Notable studies examined the persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms in China. Vaccine evaluation was a prominent theme, including a phase 2b trial of a mosaic HIV-1 vaccine regimen in southern African women and a genotypic analysis of the RTS,S/AS01E malaria vaccine in children from Ghana and Kenya. The year's publications also emphasized the molecular determinants of viral host range expansion and the global epidemiology of zoonotic avian influenza. Research directions highlighted the quantification of silent transmission and the mechanisms behind cross-species transmission. Prolific contributors included Bin Cao, Michal Juraska, and Peter B. Gilbert. These works addressed the challenges of underreported disease burden and the evolving landscape of global infectious threats.

Top Research Directions

The 5 research directions with The Lancet Infectious Diseases 2024 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Correcting Ascertainment Bias in Passive Disease Surveillance125.0%
2Distinguishing Selection from Drift in Viral Host Adaptation125.0%
3Modeling the Dynamics of Asymptomatic Pathogen Transmission125.0%
4Overcoming Pathogen Genetic Diversity in Vaccine Design125.0%
5Pathogen Spillover and Atypical Host Associations125.0%

Download all directions as CSV

Institutions

Institutions credited by The Lancet Infectious Diseases 2024 papers: a paper credits every institution named in its affiliations, once. 17 institutions share 2 credited papers.

#InstitutionPapersShare
103xasj370 150.0%
205k07p323 150.0%
305xh8jn56 150.0%
4Broad Institute 150.0%
5China Agricultural University 150.0%
6Chinese Academy of Sciences 150.0%
7Emory University 150.0%
8Fred Hutch Cancer Center 150.0%
9Fudan University 150.0%
10Harvard University 150.0%
11Kenya Medical Research Institute 150.0%
12KU Leuven 150.0%
13Shanghai First People's Hospital 150.0%
14Shanghai Jiao Tong University 150.0%
15Tulane University 150.0%
16University of California, Los Angeles 150.0%
17University of Washington 150.0%

Download all institutions as CSV

About this data

Papers. The Lancet Infectious Diseases 2024 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 4 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Lancet Infectious Diseases 2024”, https://lacuna.tiptreesystems.com/venue/the-lancet-infectious-diseases/2024.

Top Authors

AuthorPapers
Peter B. Gilbert2

Papers

Title
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Ke
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control